|
시장보고서
상품코드
1991520
폐활량계 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Spirometer Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
폐활량계 시장 규모는 2025년 9억 9,000만 달러에서 2034년에는 25억 9,000만 달러에 달할 것으로 예상되고, 2026년부터 2034년까지 CAGR 11.29%로 성장할 것으로 전망됩니다.
호흡기 건강에 대한 인식이 높아지고 폐 질환의 유병률이 증가함에 따라 전 세계 스파이로미터 시장은 눈에 띄게 성장하고 있습니다. 폐활량계는 흡입 및 호기량과 속도를 측정하여 폐 기능을 평가하는 의료기기입니다. 이 검사들은 천식, 만성폐쇄성폐질환(COPD) 등 호흡기질환의 진단 및 경과관찰에 도움이 됩니다.
시장 성장은 대기오염, 흡연, 고령화 등의 요인으로 인한 호흡기질환 사례 증가에 의해 주도되고 있습니다. 의료진은 폐 건강 상태를 평가하고 치료 방침을 결정할 때 폐활량 측정 검사에 의존하고 있습니다. 또한, 휴대용 및 디지털식 스파이로미터의 기술 발전으로 임상 현장 및 재택 의료 환경에서의 사용의 용이성과 편의성이 향상되었습니다.
의료 시스템이 호흡기질환의 조기 발견과 관리를 중시하는 가운데, 호흡기 측정기 시장의 향후 전망은 여전히 유망합니다. 디지털 헬스 플랫폼 및 모바일 애플리케이션과의 연계를 통해 환자 모니터링 및 데이터 분석을 강화할 수 있습니다. 의료 인프라의 확충과 호흡기 건강에 대한 인식이 높아지면서 시장의 지속적인 성장을 뒷받침할 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 폐활량계 시장 : 제품 유형별
제5장 세계의 폐활량계 시장 : 기술별
제6장 세계의 폐활량계 시장 : 메커니즘별
제7장 세계의 폐활량계 시장 : 질환별
제8장 세계의 폐활량계 시장 : 일회용 부품별
제9장 세계의 폐활량계 시장 : 용도별
제10장 세계의 폐활량계 시장 : 최종사용자별
제11장 세계의 폐활량계 시장 : 유통 채널별
제12장 세계의 폐활량계 시장 : 지역별
제13장 경쟁 구도
제14장 기업 개요
KSM 26.04.27The Spirometer Market size is expected to reach USD 2.59 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 11.29% during 2026-2034.
The global spirometer market has grown significantly due to increasing awareness of respiratory health and the rising prevalence of lung diseases. Spirometers are medical devices used to measure lung function by assessing the amount and speed of air inhaled and exhaled. These tests help diagnose and monitor respiratory conditions such as asthma and chronic obstructive pulmonary disease.
Market growth is driven by increasing cases of respiratory disorders caused by factors such as air pollution, smoking, and aging populations. Healthcare providers rely on spirometry tests to evaluate lung health and guide treatment decisions. Advances in portable and digital spirometers have also improved accessibility and ease of use in clinical and home healthcare settings.
The future outlook for the spirometer market remains promising as healthcare systems emphasize early detection and management of respiratory diseases. Integration with digital health platforms and mobile applications may enhance patient monitoring and data analysis. Expanding healthcare infrastructure and growing respiratory health awareness are expected to support continued market growth.
MARKET SEGMENTATION
By Product Type
- Software
- Devices (Table-Top Spirometer, Hand-Held Spirometer, PC Based Spirometer)
- Consumables and Accessories
By Technology
- Volume Measurement Spirometer
- Flow Measurement Spirometer
- Peak Flow Meter
By Mechanism
- Flow-Sensing Spirometer
- Peak Flow Meters
By Disease
- Bronchitis
- Emphysema
- Chronic Obstructive Lung Disease
- Lung Cancer
- Others
By Disposable Components
- Filters
- Sensors
- Tubes
By Application
- Asthma
- COPD
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others
By End-User
- Hospitals
- Clinics
- Homecare
By Distribution Channel
- Over the Counter
- Direct Tender
COMPANIES PROFILED
- F Hoffmann La Roche Ltd, Viatris Inc, Pfizer Inc, Sanofi SA, GSK plc, Novartis AG, Bayer AG, Merck Co Inc, AstraZeneca plc, Merck KGaA, Cipla Inc, LEO Pharma AS, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Lupin Limited
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL SPIROMETER MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Devices (Table-Top Spirometer, Hand-Held Spirometer, PC Based Spirometer) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Consumables and Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL SPIROMETER MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Technology
- 5.2. Volume Measurement Spirometer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Flow Measurement Spirometer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Peak Flow Meter Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL SPIROMETER MARKET: BY MECHANISM 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Mechanism
- 6.2. Flow-Sensing Spirometer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Peak Flow Meters Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL SPIROMETER MARKET: BY DISEASE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast Disease
- 7.2. Bronchitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Emphysema Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Chronic Obstructive Lung Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL SPIROMETER MARKET: BY DISPOSABLE COMPONENTS 2022-2034 (USD MN)
- 8.1. Market Analysis, Insights and Forecast Disposable Components
- 8.2. Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.3. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.4. Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 9. GLOBAL SPIROMETER MARKET: BY APPLICATION 2022-2034 (USD MN)
- 9.1. Market Analysis, Insights and Forecast Application
- 9.2. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.3. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.4. Cystic Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.5. Pulmonary Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 10. GLOBAL SPIROMETER MARKET: BY END-USER 2022-2034 (USD MN)
- 10.1. Market Analysis, Insights and Forecast End-user
- 10.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 10.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 10.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 11. GLOBAL SPIROMETER MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
- 11.1. Market Analysis, Insights and Forecast Distribution Channel
- 11.2. Over the Counter Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 11.3. Direct Tender Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 12. GLOBAL SPIROMETER MARKET: BY REGION 2022-2034 (USD MN)
- 12.1. Regional Outlook
- 12.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.2.1 By Product Type
- 12.2.2 By Technology
- 12.2.3 By Mechanism
- 12.2.4 By Disease
- 12.2.5 By Disposable Components
- 12.2.6 By Application
- 12.2.7 By End-user
- 12.2.8 By Distribution Channel
- 12.2.9 United States
- 12.2.10 Canada
- 12.2.11 Mexico
- 12.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.3.1 By Product Type
- 12.3.2 By Technology
- 12.3.3 By Mechanism
- 12.3.4 By Disease
- 12.3.5 By Disposable Components
- 12.3.6 By Application
- 12.3.7 By End-user
- 12.3.8 By Distribution Channel
- 12.3.9 United Kingdom
- 12.3.10 France
- 12.3.11 Germany
- 12.3.12 Italy
- 12.3.13 Russia
- 12.3.14 Rest Of Europe
- 12.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.4.1 By Product Type
- 12.4.2 By Technology
- 12.4.3 By Mechanism
- 12.4.4 By Disease
- 12.4.5 By Disposable Components
- 12.4.6 By Application
- 12.4.7 By End-user
- 12.4.8 By Distribution Channel
- 12.4.9 India
- 12.4.10 Japan
- 12.4.11 South Korea
- 12.4.12 Australia
- 12.4.13 South East Asia
- 12.4.14 Rest Of Asia Pacific
- 12.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.5.1 By Product Type
- 12.5.2 By Technology
- 12.5.3 By Mechanism
- 12.5.4 By Disease
- 12.5.5 By Disposable Components
- 12.5.6 By Application
- 12.5.7 By End-user
- 12.5.8 By Distribution Channel
- 12.5.9 Brazil
- 12.5.10 Argentina
- 12.5.11 Peru
- 12.5.12 Chile
- 12.5.13 Rest of Latin America
- 12.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.6.1 By Product Type
- 12.6.2 By Technology
- 12.6.3 By Mechanism
- 12.6.4 By Disease
- 12.6.5 By Disposable Components
- 12.6.6 By Application
- 12.6.7 By End-user
- 12.6.8 By Distribution Channel
- 12.6.9 Saudi Arabia
- 12.6.10 UAE
- 12.6.11 Israel
- 12.6.12 South Africa
- 12.6.13 Rest of the Middle East And Africa
Chapter 13. COMPETITIVE LANDSCAPE
- 13.1. Recent Developments
- 13.2. Company Categorization
- 13.3. Supply Chain & Channel Partners (based on availability)
- 13.4. Market Share & Positioning Analysis (based on availability)
- 13.5. Vendor Landscape (based on availability)
- 13.6. Strategy Mapping
Chapter 14. COMPANY PROFILES OF GLOBAL SPIROMETER INDUSTRY
- 14.1. Top Companies Market Share Analysis
- 14.2. Company Profiles
- 14.2.1 F. Hoffmann La Roche Ltd
- 14.2.2 Viatris Inc
- 14.2.3 Pfizer Inc
- 14.2.4 Sanofi S.A
- 14.2.5 GSK Plc
- 14.2.6 Novartis AG
- 14.2.7 Bayer AG
- 14.2.8 Merck & Co. Inc
- 14.2.9 AstraZeneca Plc
- 14.2.10 Merck KGaA
- 14.2.11 Cipla Inc
- 14.2.12 LEO Pharma A/S
- 14.2.13 Sun Pharmaceutical Industries Ltd
- 14.2.14 Aurobindo Pharma Ltd
- 14.2.15 Lupin Limited
